Krystal Biotech Inc
NASDAQ:KRYS

Watchlist Manager
Krystal Biotech Inc Logo
Krystal Biotech Inc
NASDAQ:KRYS
Watchlist
Price: 239.72 USD 2.17% Market Closed
Market Cap: 7B USD

Intrinsic Value

The intrinsic value of one KRYS stock under the Base Case scenario is 230.55 USD. Compared to the current market price of 239.72 USD, Krystal Biotech Inc is Overvalued by 4%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

KRYS Intrinsic Value
230.55 USD
Overvaluation 4%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Krystal Biotech Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about KRYS?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is KRYS valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Krystal Biotech Inc.

Explain Valuation
Compare KRYS to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about KRYS?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Krystal Biotech Inc

Current Assets 925.7m
Cash & Short-Term Investments 731.1m
Receivables 129.6m
Other Current Assets 64.9m
Non-Current Assets 314.4m
Long-Term Investments 133.1m
PP&E 156.3m
Other Non-Current Assets 25m
Current Liabilities 91.3m
Accounts Payable 2.1m
Accrued Liabilities 76.3m
Other Current Liabilities 12.8m
Non-Current Liabilities 11m
Other Non-Current Liabilities 11m
Efficiency

Free Cash Flow Analysis
Krystal Biotech Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Krystal Biotech Inc

Revenue
373.2m USD
Cost of Revenue
-21.4m USD
Gross Profit
351.8m USD
Operating Expenses
-193.5m USD
Operating Income
158.2m USD
Other Expenses
40.7m USD
Net Income
198.9m USD
Fundamental Scores

KRYS Profitability Score
Profitability Due Diligence

Krystal Biotech Inc's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Exceptional ROIC
ROIC is Increasing
Exceptional Operating Margin
Exceptional Gross Margin
54/100
Profitability
Score

Krystal Biotech Inc's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

KRYS Solvency Score
Solvency Due Diligence

Krystal Biotech Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Krystal Biotech Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

KRYS Price Targets Summary
Krystal Biotech Inc

Wall Street analysts forecast KRYS stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KRYS is 226.9 USD with a low forecast of 199.98 USD and a high forecast of 267.75 USD.

Lowest
Price Target
199.98 USD
17% Downside
Average
Price Target
226.9 USD
5% Downside
Highest
Price Target
267.75 USD
12% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Krystal Biotech Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for KRYS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

KRYS Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one KRYS stock?

The intrinsic value of one KRYS stock under the Base Case scenario is 230.55 USD.

Is KRYS stock undervalued or overvalued?

Compared to the current market price of 239.72 USD, Krystal Biotech Inc is Overvalued by 4%.

Back to Top